Effect of inflammation by acute sepsis on intact fibroblast growth factor 23 (iFGF23) and asymmetric dimethyl arginine (ADMA) in CKD patients

Nutr Metab Cardiovasc Dis. 2016 Jan;26(1):80-3. doi: 10.1016/j.numecd.2015.10.004. Epub 2015 Nov 4.

Authors

E Dounousi¹, C Torino², P Pizzini², S Cutrupi², V Panuccio³, G D'Arrigo², S Abd ElHafeez⁴, G Tripepi², F Mallamaci³, C Zoccali⁵

Affiliations

¹ Department of Nephrology, Medical School, University of Ioannina, Ioannina, Greece.
² CNR-IFC, Clinical Epidemiology and Physiopathology of Renal Diseases and Hypertension, Reggio Calabria, Italy.
³ Renal Unit, Reggio Calabria, Italy; CNR-IFC, Clinical Epidemiology and Physiopathology of Renal Diseases and Hypertension, Reggio Calabria, Italy.
⁴ Epidemiology Department, High Institute of Public Health, Alexandria University, Alexandria, Egypt.
⁵ CNR-IFC, Clinical Epidemiology and Physiopathology of Renal Diseases and Hypertension, Reggio Calabria, Italy. Electronic address: carmine.zoccali@tin.it.

PMID: 26712271
DOI: 10.1016/j.numecd.2015.10.004

No abstract available

Publication types

Letter

MeSH terms

Arginine / analogs & derivatives*
Arginine / blood
Biomarkers / blood
Case-Control Studies
Female
Fibroblast Growth Factor-23
Fibroblast Growth Factors / blood*
Glomerular Filtration Rate
Historically Controlled Study
Hospitalization
Humans
Inflammation / blood*
Inflammation / diagnosis
Inflammation / therapy
Inflammation Mediators / blood
Kidney / physiopathology
Longitudinal Studies
Male
Middle Aged
Renal Insufficiency, Chronic / blood*
Renal Insufficiency, Chronic / diagnosis
Renal Insufficiency, Chronic / physiopathology
Sepsis / blood*
Sepsis / diagnosis
Sepsis / therapy
Time Factors
Treatment Outcome

Substances

Biomarkers
Inflammation Mediators
Fibroblast Growth Factors
N,N-dimethylarginine
Fibroblast Growth Factor-23
Arginine